AAP
ELVN icon

Arax Advisory Partners’s Enliven Therapeutics ELVN Stock Holding History

Arax Advisory Partners’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-103
Closed -$2.32K – 2787
2024
Q4 		$2.32K Hold
103
– – ﹤0.01% 1979
2024
Q3 		$2.63K Hold
103
– – ﹤0.01% 1959
2024
Q2 		$2.41K Buy
+103
New +$2.41K ﹤0.01% 1899